As my usual monthly call to Clint, I had a promising conversation with him today. We talked about Spanish and Australian test sites - the AD trial should start soon, PDD will follow that, I am guessing. It seems everything is going well. Then we talked about Rett trial, he stated that the company is still working with the FDA - now waiting to hear from them. The goal is to have a single shot trial which will lead to an approval. So good things take time, hopefully we will get that approval eventually.
We also talked about AF article - the company recognizes all those players in the market and their intentions (especially ones with inherent unhealthy skepticism), but is relentless in getting things done in a right way as soon as possible so that the science and shareholders are the ultimate winners.. I hope so too..
Market Data 
Markets 
AI
